Optogenetics Pioneers Karl Deisseroth, Peter Hegemann and Georg Nagel Share 2026 Nobel Prize in Medicine

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to three scientists whose work illuminated how the brain's individual nerve cells can be switched on and off, a discovery that spawned the fast-growing field of optogenetics. Karl Deisseroth, Peter Hegemann and Georg Nagel were named as this year's laureates on Monday by the Nobel Assembly at the Karolinska Institute in Stockholm, opening the annual cycle of Nobel announcements.

The three researchers were honoured for their investigations into light-gated ion channels, the molecular machinery that allows certain cells to respond to illumination. That fundamental science ultimately gave rise to optogenetics, a technique that lets scientists control the activity of precisely targeted neurons using pulses of light. The Nobel committee celebrated the achievement in a post on X, noting that the method "is now being used in laboratories around the world to reveal the brain's mysteries."

Deisseroth, 54, is based at Stanford University in California, where his laboratory helped pioneer the use of light-sensitive proteins to manipulate neural circuits in living animals. Hegemann, 71, works at Humboldt University in Berlin, while Nagel, 73, is a researcher at the University of Wurzburg in Germany. The three men have collaborated across borders and disciplines, with the German scientists' work on light-responsive proteins providing a crucial foundation for the tools Deisseroth's team later refined and deployed in neuroscience.

The prize announcement marks the beginning of Nobel week, a period in which the world's most prestigious academic awards are unveiled one by one. The medicine prize is traditionally the first to be revealed, followed in quick succession by awards in physics, chemistry, literature and peace. This year's laureates will share prize money of 12 million Swedish kronor, equivalent to roughly $1.2 million, a sum that is awarded whether the recognition goes to a single individual, a small group of laureates or an organisation.

Optogenetics has transformed the way researchers study the brain, offering a level of precision that earlier techniques could not match. By introducing light-sensitive channel proteins into specific populations of neurons, scientists can activate or silence those cells within milliseconds, simply by directing a beam of light at them. This approach has allowed neuroscientists to map the circuits underlying behaviour, memory, emotion and movement with unprecedented detail, and it has opened new avenues for exploring psychiatric and neurological disorders.

The implications of the discovery extend well beyond the laboratory bench. Researchers have used optogenetic methods to probe the roots of conditions such as depression, anxiety, addiction and Parkinson's disease, and the technique is widely regarded as one of the most important methodological advances in modern neuroscience. While clinical applications remain at an early stage, the tool has already reshaped how scientists formulate questions about the brain and how they design experiments to answer them.

The Nobel Assembly's decision reflects the increasingly interdisciplinary nature of cutting-edge science. Deisseroth trained as both a neuroscientist and a psychiatrist, while Hegemann and Nagel brought expertise in biophysics and molecular biology. Their combined contributions illustrate how progress in understanding the brain often depends on insights drawn from physics, chemistry and genetics as much as from medicine itself.

Last year, the medicine prize went to three scientists whose research focused on the immune system, continuing a long tradition of honouring fundamental discoveries in biology and human health. The 2026 award to Deisseroth, Hegemann and Nagel places their work in that same lineage of breakthrough science, recognising research that initially seemed remote from clinical practice but has since become a cornerstone of experimental neuroscience.

The remainder of Nobel week will proceed with the physics prize on Tuesday, followed by chemistry on Wednesday and literature on Thursday. The peace prize is scheduled for Friday, and the Nobel Memorial Prize in Economic Sciences, established separately in memory of Alfred Nobel, will be announced on October 12. Each award carries the same prize sum of 12 million Swedish kronor, a figure that has been adjusted over the years to reflect economic conditions.

The medicine prize has long been regarded as the flagship of the Nobel awards, in part because its subject matter touches directly on human health and longevity. Over more than a century, it has recognised discoveries ranging from penicillin and the structure of DNA to the development of mRNA vaccines, each of which reshaped medicine in its own era. This year's laureates join a distinguished list of researchers whose work has deepened humanity's understanding of the nervous system.

For Deisseroth, the recognition caps a career spent at the intersection of psychiatry, neuroscience and bioengineering, where he has been a leading advocate for using precise tools to dissect the brain's circuitry. For Hegemann and Nagel, the award acknowledges decades of meticulous basic research on how microorganisms sense and respond to light, work that initially attracted little public attention but proved indispensable to the optogenetics revolution.

The Nobel committee's announcement was made at the Karolinska Institute, the medical university that has overseen the selection of medicine laureates since the prizes were first awarded in 1901. The assembly's choices are closely guarded until the moment of disclosure, and the annual ceremony in December will bring the laureates to Stockholm to receive their medals and diplomas.

Beyond the prestige, the award brings renewed attention to optogenetics as a field and to the questions it may help answer in the coming decades. Scientists continue to refine the technique, developing new light-sensitive proteins and improved delivery methods, with the long-term goal of understanding — and perhaps one day treating — disorders of the brain that have resisted conventional therapies.

As Nobel week unfolds, the medicine prize serves as a reminder of how basic curiosity-driven research can yield tools of extraordinary power. Three scientists, working in Germany and the United States, set out to understand how light can influence cellular behaviour. Their discoveries now sit at the centre of efforts to decode the most complex organ in the human body.